| 1 |
Liu, Z., Wang, X., Yu, Y., Li, X., Wang, T., Jiang, H., Ren, Q., Jiao, Y., Sawa, A., Moran, T. Ross, C. A., Montell, C. and Smith, W. W. (2008) A Drosophila model for LRRK2-linked parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 105, 2693-2698
DOI
ScienceOn
|
| 2 |
Thomas, B. and Beal, M. F. (2007) Parkinson's disease. Hum. Mol. Genet. 16 Spec No. 2, R183-R194
DOI
ScienceOn
|
| 3 |
Lewthwaite, A. J. and Nicholl, D. J. (2005) Genetics of parkinsonism. Curr. Neurol. Neurosci. Rep. 5, 397-404
DOI
ScienceOn
|
| 4 |
Belin, A. C. and Westerlund, M. (2008) Parkinson's disease: a genetic perspective. FEBS J. 275, 1377-1383
DOI
ScienceOn
|
| 5 |
Ibanez, P., Bonnet, A. M., Debarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Durr, A. and Brice, A. (2004) Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169-1171
DOI
PUBMED
ScienceOn
|
| 6 |
Chartier-Harlin, M. C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., Waucquier, N., Defebvre, L., Amouyel, P., Farrer, M. and Destee, A. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169
DOI
PUBMED
ScienceOn
|
| 7 |
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B. Stoessl, A. J., Pfeiffer, R. F., Patenge,N., Carbajal, I. C., Vieregge, P., Asmus, F., Muller-Myhsok, B., Dickson, D. W., Meitinger, T., Strom, T. M., Wszolek, Z. K. and Gasser, T. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607
DOI
ScienceOn
|
| 8 |
Lee, S. B., Kim, W., Lee, S. and Chung, J. (2007) Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila. Biochem. Biophys. Res. Commun. 358, 534-539
DOI
ScienceOn
|
| 9 |
Melrose, H., Lincoln, S., Tyndall, G., Dickson, D. and Farrer, M. (2006) Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience 139, 791-794
DOI
ScienceOn
|
| 10 |
Han, B. S., Iacovitti, L., Katano, T., Hattori, N., Seol, W. and Kim, K. S. (2008) Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra. Neurosci. Lett. 442, 190-194
DOI
ScienceOn
|
| 11 |
Unoki, M. and Nakamura, Y. (2001) Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20, 4457-4465
DOI
ScienceOn
|
| 12 |
Nichols, W. C., Pankratz, N., Hernandez, D., Paisan-Ruiz, C., Jain, S., Halter, C. A., Michaels, V. E., Reed, T., Rudolph, A., Shults, C. W., Singleton, A. and Foroud, T. (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365, 410-412
PUBMED
|
| 13 |
Mata, I. F., Kachergus, J. M., Taylor, J. P., Lincoln, S., Aasly, J., Lynch, T., Hulihan, M. M., Cobb, S. A., Wu, R. M., Lu, C. S., Lahoz, C., Wszolek, Z. K. and Farrer, M. J. (2005) Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 6, 171-177
DOI
ScienceOn
|
| 14 |
Haugarvoll, K., Rademakers, R., Kachergus, J. M., Nuytemans, K., Ross, O. A., Gibson, J. M., Tan, E. K., Gaig, C., Tolosa, E., Goldwurm, S. Guidi, M., Riboldazzi, G., Brown, L., Walter, U., Benecke, R., Berg, D., Gasser, T., Theuns, J., Pals, P., Cras, P., De Deyn, P. P., Engelborghs, S., Pickut, B., Uitti, R. J., Foroud, T., Nichols, W. C., Hagenah, J., Klein, C., Samii, A., Zabetian, C. P., Bonifati, V., Van Broeckhoven, C., Farrer, M. J. and Wszolek, Z. K. (2008) Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70, 1456-1460
DOI
PUBMED
ScienceOn
|
| 15 |
Nichols, R. J., Dzamko, N., Hutti, J. E., Cantley, L. C., Deak, M., Moran, J., Bamborough, P., Reith, A. D. and Alessi, D. R. (2009) Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem. J. 424, 47-60
DOI
ScienceOn
|
| 16 |
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K. L., Dawson, V. L. and Dawson, T. M. (2007) Parkinson's diseaseassociated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223-232
DOI
ScienceOn
|
| 17 |
Bretscher, A., Edwards, K. and Fehon, R. G. (2002) ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell. Biol. 3, 586-599
DOI
ScienceOn
|
| 18 |
Kamikawaji, S., Ito, G. and Iwatsubo, T. (2009) Identification of the autophosphorylation sites of LRRK2. Biochemistry 48, 10963-10975
DOI
ScienceOn
|
| 19 |
Narumiya, S. (1996) The small GTPase Rho: cellular functions and signal transduction. J. Biochem. 120, 215-228
DOI
PUBMED
ScienceOn
|
| 20 |
Deng, J., Lewis, P. A., Greggio, E., Sluch, E., Beilina, A. and Cookson, M. R. (2008) Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc. Natl. Acad. Sci. U.S.A. 105, 1499-1504
DOI
ScienceOn
|
| 21 |
Liu, M., Dobson, B., Glicksman, M. A., Yue, Z. and Stein, R. L. (2010) Kinetic mechanistic studies of wild-type leucine-rich repeat kinase2: characterization of the kinase and GTPase activities. Biochemistry 49, 2008-2017
DOI
ScienceOn
|
| 22 |
Wang, L., Xie, C., Greggio, E., Parisiadou, L., Shim, H., Sun, L., Chandran, J., Lin, X., Lai, C., Yang, W. J. Moore, D. J., Dawson, T. M., Dawson, V. L., Chiosis, G., Cookson, M. R. and Cai, H. (2008) The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J. Neurosci. 28, 3384-3391
DOI
ScienceOn
|
| 23 |
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J. Ahmad, R., Miller, D. W., Kesavapany, S., Singleton, A., Lees, A., Harvey, R. J., Harvey, K. and Cookson, M. R. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol. Dis. 23, 329-341
DOI
ScienceOn
|
| 24 |
Gasper, R., Meyer, S., Gotthardt, K., Sirajuddin, M. and Wittinghofer, A. (2009) It takes two to tango: regulation of G proteins by dimerization. Nat. Rev. Mol. Cell Biol. 10, 423-429
DOI
ScienceOn
|
| 25 |
Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J. M., Daniels, V., Lewis, P., Jain, S., Ding, J., Syed, A., Thomas, K. J., Baekelandt, V. and Cookson, M. R. (2008) The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem. 283, 16906-16914
DOI
ScienceOn
|
| 26 |
Ohta, E., Kubo, M. and Obata, F. (2010) Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis. Biochem. Biophys. Res. Commun. 391, 242-247
DOI
ScienceOn
|
| 27 |
Samann, J., Hegermann, J., von Gromoff, E., Eimer, S., Baumeister, R. and Schmidt, E. (2009) Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J. Biol. Chem. 284, 16482-16491
DOI
ScienceOn
|
| 28 |
Iaccarino, C., Crosio, C., Vitale, C., Sanna, G., Carri, M. T. and Barone, P. (2007) Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum. Mol. Genet. 16, 1319-1326
DOI
ScienceOn
|
| 29 |
Heo, H. Y., Park, J. M., Kim, C. H., Han, B. S., Kim, K. S. and Seol, W. (2010) LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity. Exp. Cell Res. 316, 649-656
DOI
ScienceOn
|
| 30 |
Alegre-Abarrategui, J., Christian, H., Lufino, M., Mutihac, R., Lourenco Venda, L., Ansorge, O. and Wade-Martins, R. (2009) LRRK2 regulates autophagic activity and localises to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 18, 4022-4033
DOI
ScienceOn
|
| 31 |
Tong, Y., Pisani, A., Martella, G., Karouani, M., Yamaguchi, H., Pothos, E. N. and Shen, J. (2009) R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc. Natl. Acad. Sci. U.S.A. 106, 14622-14627
DOI
ScienceOn
|
| 32 |
Johansen, K. K., Wang, L., Aasly, J. O., White, L. R., Matson, W. R., Henchcliffe, C., Beal, M. F. and Bogdanov, M. (2009) Metabolomic profiling in LRRK2-related Parkinson's disease. PLoS One 4, e7551
DOI
PUBMED
ScienceOn
|
| 33 |
Yue, Z. (2009) LRRK2 in Parkinson's disease: in vivo models and approaches for understanding pathogenic roles. FEBS J. 276, 6445-6454
DOI
ScienceOn
|
| 34 |
Kumari, U. and Tan, E. K. (2009) LRRK2 in Parkinson's disease: genetic and clinical studies from patients. FEBS J. 276, 6455-6463
DOI
ScienceOn
|
| 35 |
Braithwaite, S. P. (2009) LRRK2 in Parkinson's disease:building an understanding of disease etiology. FEBS J. 276, 6427
DOI
ScienceOn
|
| 36 |
Paisan-Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A. and Schneider, S. A. (2009) Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann. Neurol. 65, 19-23
DOI
ScienceOn
|
| 37 |
Gasser, T., Muller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P. and Horstmann, R. D. (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet. 18, 262-265
DOI
ScienceOn
|
| 38 |
Li, Y. J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W.C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Allen, F. A., Jr., Goetz, C. G., Mastaglia, F., Stajich, J. M., Gibson, R. A., Middleton, L. T., Saunders, A. M., Scott, B. L., Small, G. W., Nicodemus, K. K., Reed, A. D., Schmechel, D. E., Welsh-Bohmer, K. A., Conneally, P. M., Roses, A. D., Gilbert, J. R., Vance, J. M., Haines, J. L. and Pericak-Vance, M. A. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am. J. Hum. Genet. 70, 985-993
DOI
ScienceOn
|
| 39 |
Lautier, C., Goldwurm, S., Durr, A., Giovannone, B., Tsiaras, W. G., Pezzoli, G., Brice, A. and Smith, R. J. (2008) Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am. J. Hum. Genet. 82, 822-833
DOI
ScienceOn
|
| 40 |
Pankratz, N., Nichols, W. C., Uniacke, S. K., Halter, C., Rudolph, A., Shults, C., Conneally, P. M. and Foroud, T. (2002) Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am. J. Hum. Genet. 71, 124-135
DOI
ScienceOn
|
| 41 |
Di Fonzo, A., Dekker, M. C., Montagna, P., Baruzzi, A., Yonova, E. H., Correia Guedes, L., Szczerbinska, A., Zhao, T., Dubbel-Hulsman, L. O., Wouters, C. H. de Graaff, E. Oyen, W. J., Simons, E. J., Breedveld, G. J., Oostra, B. A., Horstink, M. W. and Bonifati, V. (2009) FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 72, 240-245
DOI
ScienceOn
|
| 42 |
Gillardon, F. (2009) Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration? J. Neurochem. 110, 1514-1522
DOI
PUBMED
ScienceOn
|
| 43 |
Saha, S., Guillily, M. D., Ferree, A., Lanceta, J., Chan, D., Ghosh, J., Hsu, C. H., Segal, L., Raghavan, K., Matsumoto, K. Matsumoto, K., Hisamoto, N., Kuwahara, T., Iwatsubo, T., Moore, L., Goldstein, L., Cookson, M. and Wolozin, B. (2009) LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J. Neurosci. 29, 9210-9218
DOI
ScienceOn
|
| 44 |
Church, W. H. and Ward, V. L. (1994) Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation. Brain Res. Bull. 33, 419-425
DOI
ScienceOn
|
| 45 |
Jaleel, M., Nichols, R. J., Deak, M., Campbell, D. G., Gillardon, F., Knebel, A. and Alessi, D. R. (2007) LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem. J. 405, 307-317
DOI
ScienceOn
|
| 46 |
Olanow, C. W. and Tatton, W. G. (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144
DOI
ScienceOn
|
| 47 |
Farrer, M., Kachergus, J., Forno, L., Lincoln, S., Wang, D. S., Hulihan, M., Maraganore, D., Gwinn-Hardy, K., Wszolek, Z., Dickson, D. and Langston, J. W. (2004) Comparison of kindreds with parkinsonism and alphasynuclein genomic multiplications. Ann. Neurol. 55, 174-179
DOI
ScienceOn
|
| 48 |
Sakaguchi-Nakashima, A., Meir, J. Y., Jin, Y., Matsumoto, K. and Hisamoto, N. (2007) LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr. Biol. 17, 592-598
DOI
ScienceOn
|
| 49 |
Imai, Y., Gehrke, S., Wang, H. Q., Takahashi, R., Hasegawa, K., Oota, E. and Lu, B. (2008) Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 27, 2432-2443
DOI
ScienceOn
|
| 50 |
Gandhi, P. N., Wang, X., Zhu, X., Chen, S. G. and Wilson-Delfosse, A. L. (2008) The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J. Neurosci. Res. 86, 1711-1720
DOI
ScienceOn
|
| 51 |
Li, X., Patel, J. C., Wang, J., Avshalumov, M. V., Nicholson, C., Buxbaum, J. D., Elder, G. A., Rice, M. E. and Yue, Z. (2010) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J. Neurosci. 30, 1788-1797
DOI
ScienceOn
|
| 52 |
Fahn, S. (2006) Levodopa in the treatment of Parkinson's disease. J. Neural. Transm. Suppl. 71, 1-15
DOI
PUBMED
|
| 53 |
Ng, C. H., Mok, S. Z., Koh, C., Ouyang, X., Fivaz, M. L., Tan, E. K., Dawson, V. L., Dawson, T. M., Yu, F. and Lim, K. L. (2009) Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J. Neurosci. 29, 11257-11162
DOI
ScienceOn
|
| 54 |
Webber, P. J. and West, A. B. (2009) LRRK2 in Parkinson's disease: function in cells and neurodegeneration. FEBS J. 276, 6436-6444
DOI
ScienceOn
|
| 55 |
Liou, A. K., Leak, R. K., Li, L. and Zigmond, M. J. (2008) Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol. Dis. 32, 116-124
DOI
ScienceOn
|
| 56 |
Li, Y., Liu, W., Oo, T. F., Wang, L., Tang, Y., Jackson-Lewis, V., Zhou, C., Geghman, K., Bogdanov, M., Przedborski, S., Beal, M. F., Burke, R. E. and Li, C. (2009) Mutant LRRK2 (R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat. Neurosci. 12, 826-828
DOI
ScienceOn
|
| 57 |
Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A. L., Roeper, J. Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I. and Kubisch, C. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191
DOI
ScienceOn
|
| 58 |
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene
cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608
DOI
ScienceOn
|
| 59 |
Greggio, E. and Cookson, M. R. (2009) Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro. 1, e00002
|
| 60 |
Gloeckner, C. J., Schumacher, A., Boldt, K. and Ueffing, M. (2009) The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro. J. Neurochem. 109, 959-968
DOI
ScienceOn
|
| 61 |
Higashi, S., Moore, D. J., Colebrooke, R. E., Biskup, S., Dawson, V. L., Arai, H., Dawson, T. M. and Emson, P. C. (2007) Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. J. Neurochem. 100, 363-381
|
| 62 |
Di Fonzo, A., Rohe, C. F., Ferreira, J., Chien, H. F., Vacca, L., Stocchi, F., Guedes, L., Fabrizio, E., Manfredi, M., Vanacore, N. Goldwurm, S., Breedveld, G., Sampaio, C., Meco, G., Barbosa, E., Oostra, B. A. and Bonifati, V. (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365, 412-415
PUBMED
|
| 63 |
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., Dehejia, A., Lavedan, C., Gasser, T., Steinbach, P. J., Wilkinson, K. D. and Polymeropoulos, M. H. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452
DOI
PUBMED
ScienceOn
|
| 64 |
Shojaee, S., Sina, F., Banihosseini, S. S., Kazemi, M. H., Kalhor, R., Shahidi, G. A., Fakhrai-Rad, H., Ronaghi, M. and Elahi, E. (2008) Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am. J. Hum. Genet. 82, 1375-1384
DOI
ScienceOn
|
| 65 |
Venderova, K., Kabbach, G., Abdel-Messih, E., Zhang, Y., Parks, R. J., Imai, Y., Gehrke, S., Ngsee, J., Lavoie, M. J., Slack, R. S. Rao, Y., Zhang, Z., Lu, B., Haque, M. E. and Park, D. S. (2009) Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease. Hum. Mol. Genet. 18, 4390-4404
DOI
ScienceOn
|
| 66 |
White, L. R., Toft, M., Kvam, S. N., Farrer, M. J. and Aasly, J. O. (2007) MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease. J. Neurosci. Res. 85, 1288-1294
DOI
ScienceOn
|
| 67 |
Ross, O. A., Wu, Y. R., Lee, M. C., Funayama, M., Chen, M. L., Soto, A. I., Mata, I. F., Lee-Chen, G. J., Chen, C. M., Tang, M., Zhao, Y., Hattori, N., Farrer, M. J., Tan, E. K. and Wu, R. M. (2008) Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann. Neurol. 64, 88-92
DOI
ScienceOn
|
| 68 |
Lesage, S., Durr, A., Tazir, M., Lohmann, E., Leutenegger, A. L., Janin, S., Pollak, P. and Brice, A. (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 354, 422-423
DOI
ScienceOn
|
| 69 |
Hulihan, M. M., Ishihara-Paul, L., Kachergus, J., Warren, L., Amouri, R., Elango, R., Prinjha, R. K., Upmanyu, R., Kefi, M., Zouari, M. Sassi, S. B., Yahmed, S. B., El Euch-Fayeche, G., Matthews, P. M., Middleton, L. T., Gibson, R. A., Hentati, F. and Farrer, M. J. (2008) LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol. 7, 591-594
DOI
ScienceOn
|
| 70 |
Ohta, E., Katayama, Y., Kawakami, F., Yamamoto, M., Tajima, K., Maekawa, T., Iida, N., Hattori, S. and Obata, F. (2009) I(2020)T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson's disease, has a higher intracellular degradation rate than the wildtype molecule. Biochem. Biophys. Res. Commun. 390, 710-715
DOI
ScienceOn
|
| 71 |
Ding, X. and Goldberg, M. S. (2009) Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS One 4, e5949
DOI
PUBMED
ScienceOn
|
| 72 |
Tan, E. K., Tan, L. C., Lim, H. Q., Li, R., Tang, M., Yih, Y., Pavanni, R., Prakash, K. M., Fook-Chong, S. and Zhao, Y. (2008) LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum. Genet. 124, 287-288
DOI
ScienceOn
|
| 73 |
Dachsel, J. C., Taylor, J. P., Mok, S. S., Ross, O. A., Hinkle, K. M., Bailey, R. M., Hines, J. H., Szutu, J., Madden, B., Petrucelli, L. and Farrer, M. J. (2007) Identification of potential protein interactors of Lrrk2. Parkinsonism Relat. Disord. 13, 382-385
DOI
ScienceOn
|
| 74 |
Tan, E. K., Zhao, Y., Skipper, L., Tan, M. G., Di Fonzo, A., Sun, L., Fook-Chong, S., Tang, S., Chua, E., Yuen, Y. Tan, L., Pavanni, R., Wong, M. C., Kolatkar, P., Lu, C. S., Bonifati, V. and Liu, J. J. (2007) The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum. Genet. 120, 857-863
DOI
ScienceOn
|
| 75 |
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S. Ferreira, J. J., Tolosa, E., Kay, D. M., Klein, C., Williams, D. R., Marras, C., Lang, A. E., Wszolek, Z. K., Berciano, J., Schapira, A. H., Lynch, T., Bhatia, K. P., Gasser, T., Lees, A. J. and Wood, N. W. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol. 7, 583-590
DOI
PUBMED
ScienceOn
|
| 76 |
Golub, Y., Berg, D., Calne, D. B., Pfeiffer, R. F., Uitti, R. J., Stoessl, A. J., Wszolek, Z. K., Farrer, M. J., Mueller, J. C., Gasser, T. and Fuchs, J. (2009) Genetic factors influencing age at onset in LRRK2-linked Parkinson disease. Parkinsonism Relat. Disord. 15, 539-541
|
| 77 |
Healy, D. G., Abou-Sleiman, P. M., Casas, J. P., Ahmadi, K. R., Lynch, T., Gandhi, S., Muqit, M. M., Foltynie, T., Barker, R., Bhatia, K. P. Quinn, N. P., Lees, A. J., Gibson, J. M., Holton, J. L., Revesz, T., Goldstein, D. B. and Wood, N. W. (2006) UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol. 59, 627-633
DOI
ScienceOn
|
| 78 |
Vilarino-Guell, C., Ross, O. A., Soto, A. I., Farrer, M. J., Haugarvoll, K., Aasly, J. O., Uitti, R. J. and Wszolek, Z. K. (2009) Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. Mov. Disord. 24, 619-620
DOI
PUBMED
ScienceOn
|
| 79 |
Lin, X., Parisiadou, L., Gu, X. L., Wang, L., Shim, H., Sun, L., Xie, C., Long, C. X., Yang, W. J., Ding, J. Chen, Z. Z., Gallant, P. E., Tao-Cheng, J. H., Rudow, G., Troncoso, J. C., Liu, Z., Li, Z. and Cai, H. (2009) Leucinerich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 64, 807-827
DOI
PUBMED
ScienceOn
|
| 80 |
Saunders-Pullman, R., Lipton, R. B., Senthil, G., Katz, M., Costan-Toth, C., Derby, C., Bressman, S., Verghese, J. and Ozelius, L. J. (2006) Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia. Neurosci. Lett. 402, 92-96
DOI
ScienceOn
|
| 81 |
Carballo-Carbajal, I., Weber-Endress, S., Rovelli, G., Chan, D., Wolozin, B., Klein, C. L., Patenge, N., Gasser, T. and Kahle, P. J. (2010) Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell Signal 22, 821-827
DOI
ScienceOn
|
| 82 |
Wang, D., Tang, B., Zhao, G., Pan, Q., Xia, K., Bodmer, R. and Zhang, Z. (2008) Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons. Mol. Neurodegener. 3, 3
DOI
ScienceOn
|
| 83 |
Anand, V. S. and Braithwaite, S. P. (2009) LRRK2 in Parkinson's disease: biochemical functions. FEBS J. 276, 6428-6435
DOI
ScienceOn
|
| 84 |
Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B., Dawson, V. L., Dawson, T. M. and Ross, C. A. (2005) Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102, 18676-18681
DOI
ScienceOn
|
| 85 |
Paisan-Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A. M., Khan, N., Johnson, J., Martinez, J. R., Nicholl, D., Carrera, I. M., Pena, A. S., de Silva, R., Lees, A., Marti-Masso, J. F., Perez-Tur, J., Wood, N. W. and Singleton, A. B. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44, 595-600
DOI
ScienceOn
|
| 86 |
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S. and Obata, F. (2002) A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann. Neurol. 51, 296-301
DOI
ScienceOn
|
| 87 |
Sancho, R. M., Law, B. M. and Harvey, K. (2009) Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum. Mol. Genet. 18, 3955-3968
DOI
ScienceOn
|
| 88 |
Shin, N., Jeong, H., Kwon, J., Heo, H. Y., Kwon, J. J., Yun, H. J., Kim, C. H., Han, B. S., Tong, Y., Shen, J. Hatano, T., Hattori, N., Kim, K. S., Chang, S. and Seol, W (2008) LRRK2 regulates synaptic vesicle endocytosis. Exp. Cell Res. 314, 2055-2065
DOI
ScienceOn
|
| 89 |
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., Albanese, A., Nussbaum, R., Gonzalez-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W. P., Latchman, D. S., Harvey, R. J., Dallapiccola, B., Auburger, G. and Wood, N. W. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160
DOI
PUBMED
ScienceOn
|
| 90 |
Korr, D., Toschi, L., Donner, P., Pohlenz, H. D., Kreft, B. and Weiss, B. (2006) LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain. Cell Signal 18, 910-920
DOI
ScienceOn
|
| 91 |
Covy, J. P. and Giasson, B. I. (2009) Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2. Biochem. Biophys. Res. Commun. 378, 473-477
DOI
ScienceOn
|
| 92 |
Halpern, C., Hurtig, H., Jaggi, J., Grossman, M., Won, M. and Baltuch, G. (2007) Deep brain stimulation in neurologic disorders. Parkinsonism Relat. Disord. 13, 1-16
DOI
ScienceOn
|
| 93 |
Gandhi, P. N., Chen, S. G. and Wilson-Delfosse, A. L. (2009) Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease. J. Neurosci. Res. 87, 1283-1295
DOI
ScienceOn
|
| 94 |
Hatano, T., Kubo, S., Imai, S., Maeda, M., Ishikawa, K., Mizuno, Y. and Hattori, N. (2007) Leucine-rich repeat kinase 2 associates with lipid rafts. Hum. Mol. Genet. 16, 678-690
DOI
ScienceOn
|
| 95 |
Kay, D. M., Kramer, P., Higgins, D., Zabetian, C. P. and Payami, H. (2005) Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Mov. Disord. 20, 1077-1078
DOI
ScienceOn
|
| 96 |
Mutez, E., Larvor, L., Lepretre, F., Mouroux, V., Hamalek, D., Kerckaert, J. P., Perez-Tur, J., Waucquier, N., Vanbesien-Mailliot, C., Duflot, A., Devos, D., Defebvre, L., Kreisler, A., Frigard, B., Destee, A. and Chartier- Harlin, M. C. (2010) Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiol. Aging. doi:10.1016/j.neurobiolaging. 2009.10.016
|
| 97 |
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L. and Dawson, T. M. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. U.S.A. 102, 16842-16847
DOI
ScienceOn
|
| 98 |
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P. Lynch, J., Healy, D. G., Holton, J. L., Revesz, T. and Wood, N. W. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365, 415-416
PUBMED
|
| 99 |
Kumar, A., Greggio, E., Beilina, A., Kaganovich, A., Chan, D., Taymans, J. M., Wolozin, B. and Cookson, M. R. (2010) The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation. PLoS One 5, e8730
DOI
PUBMED
ScienceOn
|
| 100 |
Sen, S., Webber, P. J. and West, A. B. (2009) Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J. Biol. Chem. 284, 36346-36356
DOI
ScienceOn
|
| 101 |
Guo, L., Gandhi, P. N., Wang, W., Petersen, R. B., Wilson-Delfosse, A. L. and Chen, S. G. (2007) The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp. Cell Res. 313, 3658-3670
DOI
ScienceOn
|
| 102 |
Tain, L. S., Mortiboys, H., Tao, R. N., Ziviani, E., Bandmann, O. and Whitworth, A. J. (2009) Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat. Neurosci. 12, 1129-1135
DOI
ScienceOn
|
| 103 |
Ho, C. C., Rideout, H. J., Ribe, E., Troy, C. M. and Dauer, W. T. (2009) The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J. Neurosci. 29, 1011-1016
DOI
ScienceOn
|
| 104 |
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M. and Ross, C. A. (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat. Neurosci. 9, 1231-1233
DOI
ScienceOn
|
| 105 |
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., Lipton, R. B., Soto-Valencia, J., Risch, N. and Bressman, S. B. (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354, 424-425
DOI
ScienceOn
|
| 106 |
Melrose, H. (2008) Update on the functional biology of Lrrk2. Future Neurol. 3, 669-681
DOI
PUBMED
ScienceOn
|
| 107 |
Parisiadou, L., Xie, C., Cho, H. J., Lin, X., Gu, X. L., Long, C. X., Lobbestael, E., Baekelandt, V., Taymans, J. M., Sun, L. and Cai, H. (2009) Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci. 29, 13971-13980
DOI
ScienceOn
|
| 108 |
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I. and Nussbaum, R. L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047
DOI
PUBMED
ScienceOn
|
| 109 |
Moore, D. J., West, A. B., Dawson, V. L. and Dawson, T. M. (2005) Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57-87
DOI
ScienceOn
|
| 110 |
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K. and Abeliovich, A. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52, 587-593
DOI
ScienceOn
|
| 111 |
Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T. and Iwatsubo, T. (2007) GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 46, 1380-1388
DOI
ScienceOn
|
| 112 |
Ko, H. S., Bailey, R., Smith, W. W., Liu, Z., Shin, J. H., Lee, Y. I., Zhang, Y. J., Jiang, H., Ross, C. A., Moore, D. J. Patterson, C., Petrucelli, L., Dawson, T. M. and Dawson, V. L. (2009) CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 2897-2902
DOI
ScienceOn
|
| 113 |
Lesage, S., Patin, E., Condroyer, C., Leutenegger, A. L., Lohmann, E., Giladi, N., Bar-Shira, A., Belarbi, S., Hecham, N., Pollak, P. Ouvrard-Hernandez, A. M., Bardien, S., Carr, J., Benhassine, T., Tomiyama, H., Pirkevi, C., Hamadouche, T., Cazeneuve, C., Basak, A. N., Hattori, N., Durr, A., Tazir, M., Orr-Urtreger, A., Quintana-Murci, L. and Brice, A. (2010) Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans. Hum. Mol. Genet. doi:10.1093/hmg/ddq081
|
| 114 |
Farrer, M., Wavrant-De Vrieze, F., Crook, R., Boles, L., Perez-Tur, J., Hardy, J., Johnson, W. G., Steele, J., Maraganore, D., Gwinn, K. and Lynch, T. (1998) Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Ann. Neurol. 43, 394-397
DOI
ScienceOn
|
| 115 |
Li, X., Tan, Y. C., Poulose, S., Olanow, C. W., Huang, X. Y. and Yue, Z. (2007) Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J. Neurochem. 103, 238-247
PUBMED
|
| 116 |
Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A. and Cookson, M. R. (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun. 357, 668-671
|
| 117 |
Plowey, E. D., Cherra, S. J., 3rd, Liu, Y. J. and Chu, C. T. (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J. Neurochem. 105, 1048-1056
DOI
ScienceOn
|
| 118 |
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A. Tomiyama, H., Nakashima, K., Hasegawa, K., Obata, F., Yoshikawa, T., Kawakami, H., Sakoda, S., Yamamoto, M., Hattori, N., Murata, M., Nakamura, Y. and Toda, T. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303-1307
DOI
ScienceOn
|
| 119 |
Bosgraaf, L. and Van Haastert, P. J. (2003) Roc, a Ras/GTPase domain in complex proteins. Biochim. Biophys. Acta. 1643, 5-10
DOI
ScienceOn
|
| 120 |
Simon-Sanchez, J., Herranz-Perez, V., Olucha-Bordonau, F. and Perez-Tur, J. (2006) LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain. Eur. J. Neurosci. 23, 659-666
DOI
ScienceOn
|
| 121 |
Hsu, C. H., Chan, D., Greggio, E., Saha, S., Guillily, M. D., Ferree, A., Raghavan, K., Shen, G. C., Segal, L., Ryu, H., Cookson, M. R. and Wolozin, B. (2010) MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2. J. Neurochem. 112, 1593-1604
DOI
ScienceOn
|
| 122 |
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M. van Dongen, J. W., Vanacore, N., van Swieten, J. C., Brice, A., Meco, G., van Duijn, C. M., Oostra, B. A. and Heutink, P. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259
DOI
PUBMED
ScienceOn
|
| 123 |
Nichols, W. C., Kissell, D. K., Pankratz, N., Pauciulo, M. W., Elsaesser, V. E., Clark, K. A., Halter, C. A., Rudolph, A., Wojcieszek, J., Pfeiffer, R.F. and Foroud, T. (2009) Variation in GIGYF2 is not associated with Parkinson disease. Neurology 72, 1886-1892
DOI
ScienceOn
|
| 124 |
Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A. Wolburg, H., Downward, J., Riess, O., Schulz, J. B. and Kruger, R. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099-2111
DOI
ScienceOn
|
webmaster
